Pfizer Goodwill and Intangible Assets 2010-2024 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.
Pfizer goodwill and intangible assets for 2021 were $74.354B, a 4.54% decline from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.
Pfizer goodwill and intangible assets for 2021 were $74.354B, a 4.54% decline from 2020.